Abstract

BackgroundDespite progress in cocaine immunotherapy, the kinetic and thermodynamic properties of antibodies which bind to cocaine and its metabolites are not well understood. It is also not clear how the interactions between them differ in a complex matrix such as the serum present in the human body. In the present study, we have used microscale thermophoresis (MST), isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR) we have evaluated the affinity properties of a representative mouse monoclonal (mAb08) as well as those of polyclonal antibodies purified from vaccinated mouse and human patient serum.ResultsMST analysis of fluorescently tagged mAb08 binding to cocaine reveals an approximately 15 fold decrease in its equilibrium dissociation constant in 20–50% human serum compared with that in saline buffer. A similar trend was also found using enriched polyclonal antibodies purified from vaccinated mice and patient serum, for which we have used fluorescently tagged bovine serum albumin conjugated to succinyl norcocaine (BSA-SNC). This conjugate closely mimics both cocaine and the hapten used to raise these antibodies. The ITC data also revealed that cocaine has a moderate affinity of about 2 µM to 20% human serum and very little interaction with human serum albumin or nonspecific human IgG at that concentration range. In a SPR inhibition experiment, the binding of mAb08 to immobilized BSA-SNC was inhibited by cocaine and benzoylecgonine in a highly competitive manner, whereas the purified polyclonal antibodies from vaccinated humans and mice, revealed preferential selectivity to pharmacologically active cocaine but not to the inactive metabolite benzoylecgonine. We have also developed a simple binding model to simulate the challenges associated with cocaine immunotherapy using the variable quantitative and kinetic properties of the antibodies.ConclusionsHigh sensitivity calorimetric determination of antibody binding to cocaine and its metabolites provide valuable information for characterization of their interactions and thermodynamic properties. In addition MST measurements of antibody affinity in the presence of biological fluids will provide a better opportunity to make reliable decisions and facilitate the design of cocaine vaccines and immunization conditions. The methods should be more widely adopted in characterization of antibody complexes.

Highlights

  • Cocaine addiction continues to be a source of healthcare and socioeconomic problems throughout the world

  • The antibody mAb08 was purchased from US Biological (# B1077-08) and it was raised using a benzoylecgonine hapten coupled to keyhole hemocyanin (KLH) via substituting a linker in the methyl ester position of cocaine

  • Since microscale thermophoresis (MST) can measure the interactions in complex serum, we titrated 20 nM of f-mAb08 in 20% control human serum with increasing concentrations of cocaine

Read more

Summary

Introduction

Cocaine addiction continues to be a source of healthcare and socioeconomic problems throughout the world. Since the site of pharmacological effect is inside the brain, it was hypothesized that effective blockade of cocaine entry to the brain could be attained by having high affinity anticocaine antibodies in the peripheral blood circulation [1,5] This triggered the field of immunotherapy, including both passive administration of monoclonal antibodies [6,7] and active stimulation of the patient’s immune system with conjugate vaccines to produce cocaine-specific endogenous antibodies [8,9,10]. In developing vaccines such screening options are not possible, and this issue needs to be addressed by fine tuning the hapten construction, linker, carrier proteins and adjuvants Despite these challenges great progress has been made recently in translating cocaine immunotherapy to advanced clinical trials. We have used microscale thermophoresis (MST), isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR) we have evaluated the affinity properties of a representative mouse monoclonal (mAb08) as well as those of polyclonal antibodies purified from vaccinated mouse and human patient serum

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.